Nicoya gets NRC IRAP financing to create salivation based indicative test for COVID-19 Kumar Jeetendra | June 23, 2020 Nicoya, a main supplier of cutting edge expository instruments for the biotechnology and pharmaceutical businesses, will get warning administrations and up to $299,190 in innovative work subsidizing from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to build up a compact COVID-19 demonstrative test called Atlas. This financing comes as a …
Blend of nanotechnology and hereditary designing for managing lethal malignant growth stemness Kumar Jeetendra | August 17, 2020 The development of chemotherapeutic agents with discerning anti-cancer actions is unattractive due to the emergence of resistance, inadequate targeting of cancer tissues, and subsequent metastasis. One of tumor attribute cellular types, cancer stem cells have become associated with cancer development and metastasis, representing self-renewal and their propensity to join the flow. Scientists at Japan Advanced …
BioMed X Institute Announces Expansion of their Strategic Collaboration with Janssen in Immunology Research Kumar Jeetendra | November 9, 2020 HEIDELBERG, Germany, November 09, 2020 / B3C newswire / — German independent research institute BioMed X adds a further research program in the field of immunology to their existing collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson: The new project will focus on the development of …
Utilizing a cell phone based microscope for recognizing single molecules and diagnosing infections Kumar Jeetendra | February 14, 2021 Biomarkers play a central role in the identification of disease and evaluation of its course. Among the markers now in use are genes, hormones, proteins, lipids and other types of molecules. Biomarkers can be found in the bloodstream, in cerebrospinal fluid, urine and various types of tissues, but many of them have one thing in …
Inhalation Sciences signs IRS contract worth 584,000 SEK with leading nanotech company Kumar Jeetendra | February 18, 2022 Inhalation Research Services, ISAB’s contract research organization, has signed a contract worth 584 000 SEK with a leading nanotechnology company that specializes in developing new inhalable nanoporous particles for drug delivery. The client has chosen ISAB’s unique intratracheal in vivo exposure module for its research project, due to its proven precision and reliability. The development …
From Lab to Life: How Innovation and Quality Control are Shaping the Pharma Industry Kumar Jeetendra | November 14, 2024 Driven by the need to find better therapies and save lives, the pharmaceutical industry has been motivated to invest in scientific advancement. This motivation has however not made it easy for them to bring drug creation to the market as there are a few stages involved. Aside from research, considerable quality management activities are a …
